We are live on
!
Find out more
SELLAS Life Sciences
29 hedge funds and large institutions have $21.3M invested in SELLAS Life Sciences in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 5
98% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $2.01M
61% more capital invested
Capital invested by funds: $13.3M → $21.3M (+$8.03M)
2.28% more ownership
Funds ownership: 10.29% → 12.58% (+2.3%)
6% less funds holding
Funds holding: 31 → 29 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
5
Closed
7
Calls
$3.98M
Puts
$2.01M
Net Calls
+$1.97M
Net Calls Change
+$1.64M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.45M |
| 2 |
JG
Jefferies Group
New York
|
+$1.28M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.07M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$697K |
| 5 |
State Street
Boston,
Massachusetts
|
+$366K |
Top Sellers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$1.11M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$410K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$266K |
| 4 |
VF
Virtu Financial
New York
|
-$125K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$113K |
